Literature DB >> 28195428

Blood-brain barrier breakdown in reversible cerebral vasoconstriction syndrome: Implications for pathophysiology and diagnosis.

Mi Ji Lee1, Jihoon Cha2, Hyun Ah Choi1, Sook-Young Woo3, Seonwoo Kim3, Shuu-Jiun Wang4,5, Chin-Sang Chung1.   

Abstract

OBJECTIVE: Diagnosis of reversible cerebral vasoconstriction syndrome (RCVS) is currently based on luminographic findings of vasoconstriction. In addition to vasoconstriction, the blood-brain barrier (BBB) breakdown has been postulated as a central mechanism of RCVS. Our aim was to document BBB breakdown in patients with RCVS and its role for the pathophysiology-based diagnosis of RCVS.
METHODS: We prospectively recruited 72 consecutive patients with thunderclap headache who did not have aneurysmal subarachnoid hemorrhage from April 2015 to July 2016 at the Samsung Medical Center. Based on the International Classification of Headache Disorders-3 beta criteria and neuroimaging, patients were classified as having RCVS (n = 41; "definite" in 29 imaging-proven patients and "probable" in 12 imaging-negative patients), other secondary causes (n = 7), and thunderclap headache of undetermined cause (n = 24). BBB breakdown was evaluated using contrast-enhanced fluid-attenuated inversion recovery magnetic resonance imaging.
RESULTS: BBB breakdown was documented in 20 (69.0%) patients with definite RCVS, 3 (25.0%) patients with probable RCVS, and none with other secondary causes. BBB breakdown was present in RCVS patients with (n = 4) and without (n = 19) concomitant posterior reversible encephalopathy syndrome. In patients with RCVS, the extent of BBB breakdown was independently associated with neurological complications (multivariate odds ratio = 1.48 per 1 territorial increase, 95% confidence interval = 1.04-2.12, adjusted p = 0.032). Three (12.5%) patients with thunderclap headache of undetermined cause were newly classified as having RCVS by the presence of BBB breakdown.
INTERPRETATION: This is the first study to show BBB breakdown in patients with RCVS. This finding might broaden our understanding of the pathophysiology and clinical spectrum of RCVS. Ann Neurol 2017;81:454-466.
© 2017 American Neurological Association.

Entities:  

Mesh:

Year:  2017        PMID: 28195428     DOI: 10.1002/ana.24891

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

Review 1.  Heritable and non-heritable uncommon causes of stroke.

Authors:  A Bersano; M Kraemer; A Burlina; M Mancuso; J Finsterer; S Sacco; C Salvarani; L Caputi; H Chabriat; S Lesnik Oberstein; A Federico; E Tournier Lasserve; D Hunt; M Dichgans; M Arnold; S Debette; H S Markus
Journal:  J Neurol       Date:  2020-04-21       Impact factor: 4.849

Review 2.  Potentially Reversible and Recognizable Acute Encephalopathic Syndromes: Disease Categorization and MRI Appearances.

Authors:  Y Koksel; A M McKinney
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-02       Impact factor: 3.825

3.  Leptomeningeal Carcinomatosis Mimicking Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Parneet Grewal; Julianne P Hall; Sumeet G Dua; Lauren Koffman; Rima M Dafer
Journal:  Cureus       Date:  2022-03-03

Review 4.  Reversible Cerebral Vasoconstriction Syndrome in the Postpartum Period: A Systematic Review and Meta-Analysis.

Authors:  Kimberly Pacheco; Juan Fernando Ortiz; Jashank Parwani; Claudio Cruz; Mario Yépez; Maja Buj; Mahika Khurana; Diego Ojeda; Alisson Iturburu; Alex S Aguirre; Ray Yuen; Shae Datta
Journal:  Neurol Int       Date:  2022-05-31

5.  New Syndromes Identified by Neuroimaging during Cerebral Malaria.

Authors:  Angelika Hoffmann; Samuel C Wassmer
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

Review 6.  Clinical Perspective on Primary Angiitis of the Central Nervous System in Childhood (cPACNS).

Authors:  Martin Smitka; Normi Bruck; Kay Engellandt; Gabriele Hahn; Ralf Knoefler; Maja von der Hagen
Journal:  Front Pediatr       Date:  2020-07-03       Impact factor: 3.418

Review 7.  Intracranial Large Artery Disease of Non-Atherosclerotic Origin: Recent Progress and Clinical Implications.

Authors:  Oh Young Bang; Kazunori Toyoda; Juan F Arenillas; Liping Liu; Jong S Kim
Journal:  J Stroke       Date:  2018-05-31       Impact factor: 6.967

8.  Usefulness of hyperintense acute reperfusion marker sign in patients with transient neurologic symptom.

Authors:  Jihoon Kang; Hyuksool Kwon; Cheol Kyu Jung; Hee-Joon Bae; Moon-Ku Han; Beom Joon Kim; You Hwan Jo
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

9.  Vascular wall imaging in reversible cerebral vasoconstriction syndrome - a 3-T contrast-enhanced MRI study.

Authors:  Chun-Yu Chen; Shih-Pin Chen; Jong-Ling Fuh; Jiing-Feng Lirng; Feng-Chi Chang; Yen-Feng Wang; Shuu-Jiun Wang
Journal:  J Headache Pain       Date:  2018-08-30       Impact factor: 7.277

Review 10.  The peripheral immune response after stroke-A double edge sword for blood-brain barrier integrity.

Authors:  Yan Li; Zi-Yu Zhu; Ting-Ting Huang; Yu-Xi Zhou; Xin Wang; Li-Qun Yang; Zeng-Ai Chen; Wei-Feng Yu; Pei-Ying Li
Journal:  CNS Neurosci Ther       Date:  2018-11-01       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.